A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/549 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2518676
The invention relates to the use of a composition comprising diazoxide (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine-1,1-dioxide) for the production of a medicament for the treatment and/or prevention of ischemia retinae and diseases associated with an ischemia retinae. The composition used for the above may also contain riluzole, or a derivative thereof with neuroprotective activity or a pharmaceutically-acceptable salt thereof.
La présente invention concerne l'utilisation d'une composition contenant du diazoxide (7-chloro-3méthyl-2H-~1, 2, 4-benzothiadiazine-1, 1-dioxide) pour la préparation d'un médicament destiné au traitement et/ou à la prévention d'une ischémie rétinienne et de maladies associées à une ischémie rétinienne. La composition utilisée dans le cadre de la présente invention peut en outre contenir du riluzole, du riluzole ou un dérivé actif en neuroprotection de celui-ci ou un sel pharmaceutiquement acceptable de celui-ci.
Ettaiche Mohamed
Lazdunski Michel
Centre National de La Recherche Scientifique-Cnrs
Gowling Lafleur Henderson Llp
Universite de Nice - Sophia Antipolis
LandOfFree
Use of diazoxide in the treatment of ischemia retinae does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of diazoxide in the treatment of ischemia retinae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of diazoxide in the treatment of ischemia retinae will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1777015